Regeneron Pharmaceuticals, Inc. (REGN)
698.25
-14.62
(-2.05%)
USD |
NASDAQ |
May 15, 16:00
698.50
+0.25
(+0.04%)
Pre-Market: 20:00
Regeneron Pharmaceuticals Profit Margin (Quarterly) : 20.17% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Amgen, Inc. | 21.02% |
| AbbVie, Inc. | 4.58% |
| Biogen, Inc. | 13.29% |
| Eli Lilly & Co. | 37.36% |
| Merck & Co., Inc. | -26.19% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 14.46% |
| Return on Assets | 11.21% |
| Return on Invested Capital | 13.26% |
| Gross Profit Margin (Quarterly) | 78.02% |
| Operating Margin (Quarterly) | 20.66% |
| Return on Net Operating Assets | 29.14% |